Genstar Capital, a private equity firm, completed an investment in its portfolio company ConnectiveRx, a provider of technology-enabled biopharmaceutical services. Financial terms were not disclosed. Genstar will continue as majority investor and will be joined by funds managed by Harvest Partners and funds managed by Blackstone Tactical Opportunities as minority investors. The transaction provides ConnectiveRx with enhanced financial flexibility, allowing it to continue its product innovation-driven growth, while also enabling the Company to realize an attractive outcome for its shareholders.